Cellular immunology in HIV-1 positive African American women using alcohol and cocaine

Frontiers in Bioscience

Volumn 11, Issue SUPPL. 2, 2006, Pages 2434-2441

  Chiappelli, Francesco ^a   Shapshak, Paul ^b,c   Younai, Fariba ^a   McCoy, Clyde ^b,c   Page, Bryan ^b,c,d   Prolo, Paolo ^a  

^a UCLA SCHOOL OF DENTISTRY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d Department of Biology   (United States)

Author keywords

CD4+,CD45ra+,CD4+CD45RA; Cocaethylene; Cocaine; HIV 1 seropositive; Immunopathology; Methamphetamine; Phenotype

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33744460738     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/1981     Document Type: Article

References (45)

1. McCoy, C.B. & E. Khoury: Drug use and risk of AIDS. Am Behav Sci 33, 419-31 (1990)
2. McCoy, C.B., LR. Metsch, H.V. McCoy, & S. Lai: A gender comparison of HIV and drug use across the rural-urban continuum. Popul Res Policy Rev 18, 71-87 (1999)
3. Nath, A., W.F. Maragos, M.J. Avison, F.A. Schmitt, & J.R. Berger: Acceleration of HIV dementia with methamphetamine and cocaine. J Neurovirol 7, 66-71 (2001)
4. Peterson, P.K., G. Gekker, C.C. Chao, R. Schut, T.W. Molitor & H.H. Balfour: Cocaine potentiates HIV-1 replication in human PBMNC cocultures, J Immunol 41, 81-4 (1991)
5. Peterson, PK, G. Gekker, CC, Chao, R, Schut, J, Verhoef, CK, Edelman, A, Erice & HH, Balfour: Cocaine amplifies HIV-1 replication in CMV-stimulated PBMNC cocultures, J Immunol 149, 676-80 (1992)
6. Hearn, W.L., D.D. Flynn, G.W. Hime, S. Rose & J.C. Confine: Cocaethylene: a unique cocaine metabolite displays high affinity for the dopamine transporter, J Neurochem 56, 698-701 (1991)
7. Hearn, W.L., S. Rose, J. Wagner, A. Ciarleglio & D.C. Mash: Cocaethylene is more potent than cocaine in mediating lethality. Pharmacol Biochem Behav 39, 531-3, (1991)
8. Shapshak, P: Cocaine and metabolites stimulate HIV replication in neural cells, College on Problems of Drug Dependence, 54th Annual Scientific Meeting, Keystone, Colorado, June 20-26, (1992)
9. Shapshak, P., D. Mash, L. Hearn, M. Yoshioka, S. Nelson, L. Tate & M.A. Fletcher: Detection of HIV in CNS tissue and cells and effects of cocaine and metabolites, in vitro, Committee on Problems of Drug Dependence, 53rd Annual Scientific Meeting, Palm Beach, Florida, June 16-20, (1991)
10. Xin, K.Q., P. Shapshak, I. Nagano, R. Stewart, M. Yoshioka, S. Nakamura, C. McCoy, W. Bradley, N. Weatherby, D. Mash, A.K. Srivastava, M. Fiala, N.C.J. Sun, F. Chiappelli, K. Okuda, V. Pardo, K. Goodkin, S. Lai, C. Wood, S.M. Shah, T. Davis, M. Perez, G. Cuelez, B. Fernandez: AIDS Pathogenesis: drug abuse, cytokines, and viral strain, 10th International Conference on AIDS, Yokohama, Japan, Amicrogramust 7-12th, (1994)
11. Duncan, R., P. Shapshak, J.B. Page, F. Chiappelli, S.E. Messiah & C.B. McCoy: Crack cocaine: effect modifier of RNA viral load and CD4 count in HIV infected African American women, Front Biosci (In Press, 2006)
12. Goodkin, K., P. Shapshak, L. Metsch, C.B. McCoy, K.A. Crandall, M. Kumar, R.K. Fujimura, V. McCoy, B.T. Zhang, S. Reyblat, K.Q. Xin & A.M. Kumar: Cocaine abuse and HIV-1: epidemiology and neuropathogenesis. Special Issue, J Neuroimmunol 83, 88-101 (1998)
13. Roth, M.D., D.P. Tashkin, R. Choi, B.D. Jamieson, J.A. Zack & G.C. Baldwin: Cocaine enhances human immunodeficiency virus replication in a model of severe combined immunodeficient mice implanted with human peripheral blood leukocytes. J Infect Dis 185, 701-5 (2002)
14. Ruiz, P., T. Cleary, M. Nassiri & B. Steele: Human T cell subpopulation and NK cell alterations in persons exposed to cocaine. Clinical Immunol Immunopathol 70:245-50 (1994)
15. Nair, M.P.N., K.C. Chada, R.G. Hewitt, S. Mahajan, A. Sweet & S.A. Schwartz: Cocaine differentially modulates chemokine production by mononuclear cells from normal donors and Human Immunodeficiency Virus Type-1 infected patients. Clin Diag Immunol 7:96-100 (2000)
16. Fiala, M., X.-H. Gan, T. Newton, F. Chiappelli, P. Shapshak, V. Kermani, M.A. Kung, A. Diagne, O. Martinez, M. Graves, D. Way, M. Weinand & M. Witte: Divergent effects of cocaine on cytokine production by lymphocytes and monocyte/macrophages. Chap 20, pp. 145-156. In AIDS, Drug of Abuse and the Neuroimmune Axis. H. Friedman, J. Madden, B. Sharp, T. Eisenstein, Eds. Plenum Press, (1996)
17. Fiala, M., X.-H. Gan, L. Zhang, S.D. House, T. Newton, M. Graves, P. Shapshak, M. Stins, K.S. Kim, M. Witte & S.L. Chang: Cocaine enhances monocyte migration across the blood-brain barrier, Cocaine's connection to AIDS Dementia and Vasculitis. Adv in Exp Med and Biol, Drugs of Abuse, Immunomodulation, and AIDS (ed. H. Friedman), 199-205, Plenum Press, (1998)
18. Chiappelli, F., P. Frost, E. Manfrini, P. Lee, L. Pham, C. Garcia, S. Daley, M.A. Kung & P. Villanueva: Cocaine blunts human CD4+ cell activation. Immunopharmacol 28, 233-40 (1994)
19. Bagasra, O. & L. Forman: Functional analysis of lymphocyte subpopulations in experimental cocaine abuse. I. Dose-dependent activation of lymphocyte subsets. Clin Exp Immunol 77, 289-93 (1989)
20. Bagasra, O., A. Kajdacsy-Balla, H.W. Lischner & R.J. Pomerantz R.J: Alcohol intake increases human immunodeficiency virus type 1 replication in human perpheral blood mononuclear cells. J Inf Pis 167, 789-97 (1993)
21. Chiappelli, F., M.A. Kung, P. Villanueva, P. Lee, P. Frost & N. Prieto: Immunotoxicity of cocaethylene. Immunopharmacol Immunotoxicol 17, 399-417 (1995)
22. Moss, A.R.: Predicting who will progress to AIDS. British Med J 297, 1067-8 (1988)
23. Giorgi, J.V., A.M. Kesson & C.-C. Chou: Immunodeficiency and infectious diseases. In Manual of clinical laboratory immunology NR Rose EC de Macario JL Fahey H Freiman GM Penn Eds 4th Ed pp. 174-181. (1992)
24. Fahey, J.L., J. M.G. Taylor, R. Detels, B. Hofmann, R. Melmed, P. Nishanian & J. Giorgi: The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. New Eng J Med 322, 166-72 (1990)
25. Walker, C.M., D.J. Moody, D.P. Stites & J.A. Levy: CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 234, 1563-6 (1986)
26. Hoffenbach, A., P. Langlade-Demoyen, G. Dadaglio, E. Vilmer, F. Michel, C. Mayaud, B. Autran & F. Plata: Unusually high frequencies of HIV-specific cytotoxic T lymphocytes in humans. J Immunol 142, 452-62 (1989)
27. Vanham, G., L. Kestens, G. Penne, C. Goilav, P. Gigase, R. Colebunders, M. Vandenbrueane, J. Goeman, G. van der Groen & J.L. Ceuppens: Subset markers of CD8(+) cells and their relation to enhanced cytotoxic T-cell activity during human immunodeficiency virus infection. J Clin Immunol 11, 345-56 (1991)
28. Ho, H.N., L.E. Hutlin, R.T. Mitsuyasu, J.L. Matud, M.A. Hausner, D. Bockstoce, C.C. Chou, S. O'Rourke, J.M. Taylor & J. Giorgi: Circulating HIV-specific CD8+ cytotoxic T cells express CD38 and HLA-Dr antigens. J Immunol 150 3070-9 (1993)
29. Giorgi, J.V., Z. Liu, L.E. Hutlin, W.G. Cumberland, K. Hennessey & R. Detels: Elevated levels of CD8+CD38+ T cells in HIV infection add to the prognostic value of low CD4+ T cell levels: Results of 6 years of follow-up. J Acq Imm Def Syn 6, 904-12 (1993)
30. Miedema, F., M. Termette & R.A.W. van Lier: AIDS pathogenesis: a dynamic interaction between HIV and the immune system. Immunol Today 11, 17-22 (1990)
31. Mihailov, C., A. Lamour, V. Beaudre-Bellein, N. Jezequel, M. Garre, D. Mortier, G. Guillet & P. Youinou: Prognostic significance of cytotoxic T cells in individuals infected with human immunodeficiency virus. J Clin Immunol 13, 139-44 (1993)
32. Clerici, M. & G.M. Shearer: A TH1->TH2 switch is a critical step in the etiology of HIV infection. Immunol Today 14, 107-111 (1993)
33. Romagnani, S., E. Maggi & G. del Prete G: An alternative view of the TH1/TH2 switch hypothesis in HIV infection. AIDS res Human Retrovirus 10 ii-ix (1993)
34. Maggi, E., M. Mazzetti, A. Ravina, F. Annunziato, M. de Carli, M.P. Piccini, R. Manetti, M. Carbonari, A.M. Pesce, G. del Prete & S. Romagnani: (1994) Ability of HIV to promote TH1 to THO shift and to replicate preferentially in TH2 and THO cells. Science 265, 244-8 (1994)
35. Graziosi, C., G. Pantaleo, K.R. Gantt, J.P Fortin, J.F. Demarest, O.J. Cohen, R.P. Sekaly & A.S. Fauci: Lack of evidence for the dichotomy of TH1 and TH2 predominance in HIV-infected individuals. Science 265, 248-52 (1994)
36. Autran, B., E. Legac, C. Blanc & P. Debre: A THO/TH2-like function CD4 + CD7-T helper cells from normal donors and HIV-infected patients. J Immunol 154, 1408-17 (1995)
37. Gruters, R.A., F.G. Terpstra, R. De Jong, C.J.M. van Noesel, R.A.W. van Lier & F. Miedema: Selective loss T cell function in different stages of HIV infection. Eur J Immunol 20, 1039-44 (1990)
38. O'Toole, S.M., F. Chiappelli & R.T. Rubin: Plasma neopterin in Major Depression: Relationship to basal and stimulated pituitary-adrenal cortical axis function. Psychiat Res 79, 21-9 (1998)
39. Kaslow, R.A., W.C. Blackwelder, D.G Ostrow, D. Yerg, J. Palenicek, A.M. Coulson & R.O. Valdiserri: O (1989) No evidence for a role of alcohol or other psychoactive drugs in accelerating immunodeficiency in HIV-1-positive individuals. JAMA 261, 3424-9 (1989)
40. Rezza, G., A. Lazzarin, G. Angarano, R. Zerboni, A. Sinico, B. Salassa, R. Pristera, M. Barbanera, L. Ortona, F. Aiuti, P. Costigliola, S. Gafa, U. Tirella, P. Pezzotti & F. Menniti-Ippolito: Risk of AIDS in HIV seroconverters: A comparison between intravenous drug users and homosexual males. Eur J Epidemiol 6, 99-101 (1990)
41. Mariotto, A.B., S. Mariotti, P. Pezzotti, G. Rezza & A. Verdecchia: Estimation of the acquired immunodeficiency syndrome incubation period in intravenous drmicrogram users: A comparison with male homosexuals. Am J Epidemiol 135, 428-37 (1992)
42. Chiappelli, F., M.A. Kung, P. Lee, L. Pham, E. Manfrini & P. Villanueva: Alcohol modulation of human normal T cell activation, maturation and migration. Alcohl: Exp Clin Res 19, 539-44 (1995)
43. Leigh, J.E., C. Steele, F.L. Wormley Jr, W. Luo, R.A. Clark, W. Gallaher & P.L. Fidel Jr: Th1/Th2 cytokine expression in saliva of HIV-positive and HIV-negative individuals: a pilot study in HIV-positive individuals with oropharyngeal candidiasis. J Acq Immune Def Synd Human Retrovirol 19, 373-80 (1998)
44. House, R.V., P.T. Thomas & H.N. Bhargava: Comparison of immune functional parameters following in vitro exposure to natural and synthetic amphetamines. Immunopharmacol Immunotoxicol 16, 1-21 (1994)
45. Chiappelli, F., P. Prolo, M. Fiala, O. Cajulis, J. Iribarren, A. Panerai, N. Neagos F. Younai & G. Bernard:. Allostasis in HIV Infection and AIDS. In Neuro-AIDS. PA Minagar & P Shapshak, Eds. Nova Science Publisher, Inc. (Hauppauge, NY) (In Press 2006)